NGM BIOPHARMACEUTICALS INC (NGM) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 620 transactions totaling $376.7M, demonstrating a bullish sentiment with $351.1M in net insider flow. The most recent transaction on Apr 5, 2024 involved a transaction of 19,349 shares valued at $0.
No significant insider buying has been recorded for NGM in the recent period.
No significant insider selling has been recorded for NGM in the recent period.
Based on recent SEC filings, insider sentiment for NGM is bullish with an Insider Alignment Score of 97/100 and a net flow of $351.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NGM BIOPHARMACEUTICALS INC (NGM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading NGM stock, having executed 620 transactions in the past 90 days. The most active insider is David Goeddel V (Executive), who has made 147 transactions totaling $87.9M.
Get notified when executives and directors at NGM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 5, 2024 | D. Lieu Hsiao | Executive | Tender | 19,349 | $N/A | $0 | |
| Apr 5, 2024 | Sawochka Hooper Suzanne | Executive | Tender | 7,000 | $N/A | $0 | |
| Apr 5, 2024 | Perlich Irene | Executive | Tender | 6,284 | $N/A | $0 | |
| Apr 5, 2024 | J. Woodhouse David | Executive | Tender | 97,654 | $N/A | $0 | |
| Apr 5, 2024 | J. Woodhouse David | Executive | Tender | 23,993 | $N/A | $0 | |
| Apr 5, 2024 | Viret Jean-frederic | Executive | Tender | 3,038 | $N/A | $0 | |
| Apr 5, 2024 | Jl Rieflin William | Executive | Tender | 5,172 | $N/A | $0 | |
| Apr 5, 2024 | Jl Rieflin William | Executive | Tender | 2,769,168 | $N/A | $0 | |
| Apr 5, 2024 | L. Pierce Valerie | Executive | Tender | 26,458 | $N/A | $0 | |
| Apr 5, 2024 | Goeddel David V | Executive | Other | 1,000 | $N/A | $0 | |
| Apr 5, 2024 | Goeddel David V | Executive | Disposition | 134,180 | $N/A | $0 | |
| Apr 5, 2024 | Goeddel David V | Executive | Disposition | 190,000 | $N/A | $0 | |
| Apr 5, 2024 | Goeddel David V | Executive | Disposition | 949,862 | $N/A | $0 | |
| Apr 5, 2024 | Goeddel David V | Executive | Disposition | 2,650,177 | $N/A | $0 | |
| Apr 5, 2024 | Goeddel David V | Executive | Disposition | 90,442 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 472 | $363.9M | 96.2% |
Sale(S) | 46 | $12.8M | 3.4% |
Exercise(M) | 20 | $1.6M | 0.4% |
Payment(F) | 4 | $32.8K | 0.0% |
Tender(U) | 9 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Disposition(D) | 52 | $0 | 0.0% |
Award(A) | 5 | $0 | 0.0% |
Conversion(C) | 8 | $0 | 0.0% |
Insiders at NGM BIOPHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 35 insiders making 620 transactions totaling $363.9M in purchases versus $12.8M in sales, the net buying activity of $351.1M signals strong executive confidence. David Goeddel V (Executive) leads the buying activity with $87.9M in transactions across all time.